These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26826992)

  • 1. [Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
    Nogués MA; Varela FJ; Seminario G; Insúa MC; Bezrodnik L
    Medicina (B Aires); 2016; 76(1):36-9. PubMed ID: 26826992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.
    Markvardsen LH; Debost JC; Harbo T; Sindrup SH; Andersen H; Christiansen I; Otto M; Olsen NK; Lassen LL; Jakobsen J;
    Eur J Neurol; 2013 May; 20(5):836-42. PubMed ID: 23294032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
    van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
    Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years.
    Gentile L; Mazzeo A; Russo M; Arimatea I; Vita G; Toscano A
    Sci Rep; 2020 May; 10(1):7910. PubMed ID: 32404895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
    Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R
    Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
    Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
    Racosta JM; Sposato LA; Kimpinski K
    Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response.
    Cocito D; Romagnolo A; Peci E; Rosso M; Lopiano L; Milla P; Merola A
    J Peripher Nerv Syst; 2016 Jun; 21(2):114-6. PubMed ID: 27251938
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study.
    Markvardsen LH; Sindrup SH; Christiansen I; Olsen NK; Jakobsen J; Andersen H;
    Eur J Neurol; 2017 Feb; 24(2):412-418. PubMed ID: 28000311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N
    J Peripher Nerv Syst; 2006 Mar; 11(1):88-9; author reply 90-1. PubMed ID: 16519787
    [No Abstract]   [Full Text] [Related]  

  • 11. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
    Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy.
    Allen JA; Gorson KC; Gelinas D
    Brain Behav; 2018 Mar; 8(3):e00932. PubMed ID: 29541543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?
    Cocito D; Merola A; Romagnolo A; Peci E; Toscano A; Mazzeo A; Gentile L; Russo M; Fazio R; Filosto M; Siciliano G; Schirinzi E; Nobile-Orazio E; Lopiano L
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):791-3. PubMed ID: 26109674
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
    Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin.
    Cocito D; Serra G; Falcone Y; Paolasso I
    J Peripher Nerv Syst; 2011 Jun; 16(2):150-2. PubMed ID: 21692916
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin.
    Markvardsen LH; Vaeggemose M; Ringgaard S; Andersen H
    Neuroradiology; 2016 Aug; 58(8):745-52. PubMed ID: 27114080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
    Rajabally YA
    Muscle Nerve; 2015 May; 51(5):657-61. PubMed ID: 25556954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CIDP diagnostic pitfalls and perception of treatment benefit.
    Allen JA; Lewis RA
    Neurology; 2015 Aug; 85(6):498-504. PubMed ID: 26180143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy.
    Lucke IM; Adrichem ME; Wieske L; van der Kooi AJ; Verhamme C; van Schaik IN; Eftimov F
    J Neurol Sci; 2019 Feb; 397():141-145. PubMed ID: 30623818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.